Pixarbio (OTCMKTS:PXRB) and Planet Fitness (NYSE:PLNT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings and profitability.

Risk and Volatility

Pixarbio has a beta of -185.98, suggesting that its stock price is 18,698% less volatile than the S&P 500. Comparatively, Planet Fitness has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500.

Insider and Institutional Ownership

94.1% of Planet Fitness shares are owned by institutional investors. 16.4% of Planet Fitness shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and target prices for Pixarbio and Planet Fitness, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pixarbio 0 0 0 0 N/A
Planet Fitness 0 4 8 0 2.67

Planet Fitness has a consensus target price of $51.85, suggesting a potential upside of 1.46%. Given Planet Fitness’ higher possible upside, analysts clearly believe Planet Fitness is more favorable than Pixarbio.

Profitability

This table compares Pixarbio and Planet Fitness’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pixarbio N/A N/A N/A
Planet Fitness 11.22% -95.97% 8.92%

Valuation and Earnings

This table compares Pixarbio and Planet Fitness’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pixarbio $1.97 billion 0.00 -$1.00 million N/A N/A
Planet Fitness $429.94 million 11.70 $33.14 million $0.84 60.83

Planet Fitness has lower revenue, but higher earnings than Pixarbio.

Summary

Planet Fitness beats Pixarbio on 9 of the 11 factors compared between the two stocks.

About Pixarbio

PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson's disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. The company is based in Medford, Massachusetts.

About Planet Fitness

Planet Fitness, Inc., together with its subsidiaries, franchises and operates fitness centers under the Planet Fitness name. It operates through three segments: Franchise, Corporate-Owned Stores, and Equipment. The Franchise segment is involved in franchising business in the United States, Puerto Rico, Canada, the Dominican Republic, and Panama. The Corporate-Owned Stores segment operates corporate-owned stores in the United States and Canada. The Equipment segment engages in the sale of fitness equipment to franchisee-owned stores in the United States. As of June 30, 2018, the company had 1,608 stores in 50 states, the District of Columbia, Puerto Rico, Canada, the Dominican Republic, Panama, and Mexico. Planet Fitness, Inc. was founded in 1992 and is headquartered in Hampton, New Hampshire.

Receive News & Ratings for Pixarbio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pixarbio and related companies with MarketBeat.com's FREE daily email newsletter.